[144] Orchestra BioMed Holdings, Inc. SEC Filing

Rhea-AI Filing Summary

Orchestra BioMed Holdings Director Eric S. Fain has filed a Form 144 notice for the proposed sale of 2,683 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of $8,194.15.

Key details of the transaction:

• The shares were acquired on June 25, 2025, through restricted stock vesting as compensation
• The sale is planned for June 26, 2025, on NASDAQ
• The sale is being conducted to cover tax obligations from a vested equity award distribution
• The transaction will be executed through the Fain Living Trust, where Eric S. Fain serves as trustee

The filing indicates that the seller has no knowledge of undisclosed material adverse information regarding Orchestra BioMed's operations. The company currently has 38,312,512 shares outstanding.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001402222
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Orchestra BioMed Holdings, Inc.
SEC File Number	001-39421
Address of Issuer	150 UNION SQUARE DRIVE NEW HOPE PENNSYLVANIA 18938
Phone	646-343-9298
Name of Person for Whose Account the Securities are To Be Sold	Fain Eric S
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2683	8194.15	38312512	06/26/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/25/2025	Restricted Stock Vesting	Issuer			2683	06/25/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution. This sale occurred in the Fain Living Trust account of which Eric S. Fain is a trustee.
Date of Notice	06/26/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Eric Steven Fain
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many shares of OBIO stock is Director Eric Fain selling on June 26, 2025?

According to the Form 144 filing, Director Eric Fain is selling 2,683 shares of OBIO common stock through Fidelity Brokerage Services LLC, with an aggregate market value of $8,194.15.

What is the reason for Eric Fain's OBIO stock sale in June 2025?

The Form 144 filing indicates that the sale is to cover a tax obligation resulting from the settlement of a vested equity award distribution. The shares were acquired through Restricted Stock Vesting on June 25, 2025, as part of compensation.

What is the total number of OBIO shares outstanding as of June 2025?

According to the Form 144 filing, Orchestra BioMed Holdings, Inc. (OBIO) has 38,312,512 shares outstanding as of the filing date.

Has OBIO Director Eric Fain sold any other shares in the past 3 months?

No, according to the Form 144 filing section 'Securities Sold During The Past 3 Months,' there were no other sales reported by Eric Fain during this period.

Through which trust account is Eric Fain selling OBIO shares?

According to the remarks section of the Form 144 filing, the sale is occurring through the Fain Living Trust account, of which Eric S. Fain is a trustee.